177 related articles for article (PubMed ID: 33637888)
1. The impact of unsolicited findings in clinical exome sequencing, a qualitative interview study.
Schoot VV; Viellevoije SJ; Tammer F; Brunner HG; Arens Y; Yntema HG; Oerlemans AJM
Eur J Hum Genet; 2021 Jun; 29(6):930-939. PubMed ID: 33637888
[TBL] [Abstract][Full Text] [Related]
2. Lessons learned from unsolicited findings in clinical exome sequencing of 16,482 individuals.
van der Schoot V; Haer-Wigman L; Feenstra I; Tammer F; Oerlemans AJM; van Koolwijk MPA; van Agt F; Arens YHJM; Brunner HG; Vissers LELM; Yntema HG
Eur J Hum Genet; 2022 Feb; 30(2):170-177. PubMed ID: 34697415
[TBL] [Abstract][Full Text] [Related]
3. Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.
Delanne J; Nambot S; Chassagne A; Putois O; Pelissier A; Peyron C; Gautier E; Thevenon J; Cretin E; Bruel AL; Goussot V; Ghiringhelli F; Boidot R; Tran Mau-Them F; Philippe C; Vitobello A; Demougeot L; Vernin C; Lapointe AS; Bardou M; Luu M; Binquet C; Lejeune C; Joly L; Juif C; Baurand A; Sawka C; Bertolone G; Duffourd Y; Sanlaville D; Pujol P; Geneviève D; Houdayer F; Thauvin-Robinet C; Faivre L
Eur J Med Genet; 2019 Jun; 62(6):103529. PubMed ID: 30165243
[TBL] [Abstract][Full Text] [Related]
4. Clinical geneticists' views on and experiences with unsolicited findings in next-generation sequencing: "A great technology creating new dilemmas".
van der Schoot V; Damsté C; Yntema HG; Brunner HG; Oerlemans AJM
J Genet Couns; 2023 Apr; 32(2):387-396. PubMed ID: 36366912
[TBL] [Abstract][Full Text] [Related]
5. Parents, their children, whole exome sequencing and unsolicited findings: growing towards the child's future autonomy.
Tibben A; Dondorp W; Cornelis C; Knoers N; Brilstra E; van Summeren M; Bolt I
Eur J Hum Genet; 2021 Jun; 29(6):911-919. PubMed ID: 33456055
[TBL] [Abstract][Full Text] [Related]
6. Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.
Robinson JO; Wynn J; Biesecker B; Biesecker LG; Bernhardt B; Brothers KB; Chung WK; Christensen KD; Green RC; McGuire AL; Hart MR; Griesemer I; Patrick DL; Rini C; Veenstra D; Cronin AM; Gray SW
Genet Med; 2019 Dec; 21(12):2781-2790. PubMed ID: 31189963
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing in pediatrics: parents' considerations toward return of unsolicited findings for their child.
Cornelis C; Tibben A; Dondorp W; van Haelst M; Bredenoord AL; Knoers N; Düwell M; Bolt I; van Summeren M
Eur J Hum Genet; 2016 Dec; 24(12):1681-1687. PubMed ID: 27460421
[TBL] [Abstract][Full Text] [Related]
8. A qualitative study among patients with an inherited retinal disease on the meaning of genomic unsolicited findings.
Saelaert M; Mertes H; Moerenhout T; Van Cauwenbergh C; Leroy BP; Devisch I; De Baere E
Sci Rep; 2021 Aug; 11(1):15834. PubMed ID: 34349199
[TBL] [Abstract][Full Text] [Related]
9. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
Ackerman SL; Koenig BA
AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
[TBL] [Abstract][Full Text] [Related]
10. Gratitude, protective buffering, and cognitive dissonance: How families respond to pediatric whole exome sequencing in the absence of actionable results.
Werner-Lin A; Zaspel L; Carlson M; Mueller R; Walser SA; Desai R; Bernhardt BA
Am J Med Genet A; 2018 Mar; 176(3):578-588. PubMed ID: 29446570
[TBL] [Abstract][Full Text] [Related]
11. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
Ormondroyd E; Moynihan C; Watson M; Foster C; Davolls S; Ardern-Jones A; Eeles R
J Genet Couns; 2007 Aug; 16(4):527-38. PubMed ID: 17492498
[TBL] [Abstract][Full Text] [Related]
12. Physicians' perceptions of the factors influencing disclosure of secondary findings in tumour genomic profiling in Japan: a qualitative study.
Shimada S; Yamada T; Iwakuma M; Kosugi S
Eur J Hum Genet; 2022 Jan; 30(1):88-94. PubMed ID: 34400810
[TBL] [Abstract][Full Text] [Related]
13. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings.
Boardman F; Hale R
Mol Genet Genomic Med; 2018 Nov; 6(6):1079-1096. PubMed ID: 30370638
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic exome sequencing in children: A survey of parental understanding, experience and psychological impact.
Wynn J; Ottman R; Duong J; Wilson AL; Ahimaz P; Martinez J; Rabin R; Rosen E; Webster R; Au C; Cho MT; Egan C; Guzman E; Primiano M; Shaw JE; Sisson R; Klitzman RL; Appelbaum PS; Lichter-Konecki U; Anyane-Yeboa K; Iglesias A; Chung WK
Clin Genet; 2018 May; 93(5):1039-1048. PubMed ID: 29266212
[TBL] [Abstract][Full Text] [Related]
15. Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing.
Godino L; Varesco L; Bruno W; Bruzzone C; Battistuzzi L; Franiuk M; Miccoli S; Bertonazzi B; Graziano C; Seri M; Turchetti D
J Genet Couns; 2021 Jun; 30(3):665-675. PubMed ID: 33142017
[TBL] [Abstract][Full Text] [Related]
16. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
Horiuchi Y; Matsubayashi H; Kiyozumi Y; Nishimura S; Higashigawa S; Kado N; Nagashima T; Mizuguchi M; Ohnami S; Arai M; Urakami K; Kusuhara M; Yamaguchi K
Hum Genet; 2021 Feb; 140(2):321-331. PubMed ID: 32710294
[TBL] [Abstract][Full Text] [Related]
17. Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres.
Saelaert M; Mertes H; Moerenhout T; De Baere E; Devisch I
BMC Med Genomics; 2019 Aug; 12(1):123. PubMed ID: 31429751
[TBL] [Abstract][Full Text] [Related]
18. When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.
Jamal L; Robinson JO; Christensen KD; Blumenthal-Barby J; Slashinski MJ; Perry DL; Vassy JL; Wycliff J; Green RC; McGuire AL
AJOB Empir Bioeth; 2017; 8(2):82-88. PubMed ID: 28949844
[TBL] [Abstract][Full Text] [Related]
19. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
[TBL] [Abstract][Full Text] [Related]
20. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
